| P50 | author | Brian Greenwood | Q4963885 |
| | Michel M Dione | Q55172429 |
| | Richard Adebayo Adegbola | Q75114791 |
| | Anna Roca | Q103000144 |
| P2093 | author name string | Philip C Hill | |
| | Martin Antonio | |
| | Stephen R C Howie | |
| | Abdoulie Bojang | |
| | John Townend | |
| | Ousainou Darboe | |
| | Uzochukwu Egere | |
| P2860 | cites work | Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae | Q58097503 |
| | A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae | Q73255362 |
| | Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B | Q73281054 |
| | Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers | Q77838494 |
| | Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers | Q80124522 |
| | Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine | Q81402633 |
| | Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine | Q22250891 |
| | Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates | Q28258300 |
| | Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study | Q28270868 |
| | Vaccine escape recombinants emerge after pneumococcal vaccination in the United States | Q33306103 |
| | Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine | Q33343077 |
| | Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial | Q33986009 |
| | Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial | Q34058016 |
| | Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete | Q34235508 |
| | Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates | Q34315537 |
| | Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae | Q35066378 |
| | Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities | Q35628669 |
| | Pneumococcal antibody concentrations and carriage of pneumococci more than 3 years after infant immunization with a pneumococcal conjugate vaccine | Q35766567 |
| | Postvaccination increase in serotype 19A pneumococcal disease in Norway is driven by expansion of penicillin-susceptible strains of the ST199 complex | Q35805223 |
| | Pneumococcal serotypes in children in 4 European countries | Q35806522 |
| | Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal | Q37871521 |
| | The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A. | Q38366436 |
| | Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains | Q38500243 |
| | National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential | Q39962170 |
| | Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. | Q40166390 |
| | Sequential multiplex PCR for determining capsular serotypes of pneumococci recovered from Brazilian children | Q43582290 |
| | Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine | Q43608796 |
| | Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings. | Q45964682 |
| | Transmission of Streptococcus pneumoniae in rural Gambian villages: a longitudinal study | Q46690608 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | The Gambia | Q1005 |
| | cluster randomized trial | Q108841646 |
| P304 | page(s) | e72198 | |
| P577 | publication date | 2013-09-27 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Nasopharyngeal carriage of pneumococci four years after community-wide vaccination with PCV-7 in The Gambia: long-term evaluation of a cluster randomized trial | |
| P478 | volume | 8 | |